PUBLIC CONTRACT · 2017
1008O17 - Medicamento Exclusivo Hepatite C - Gilead
- Contract value
- €123,494.51
- Signed on
- 9 February 2017
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3128979PUBLISHED SUBJECT
1008O17 - Medicamento Exclusivo Hepatite C - Gilead
Parties involved
- Awardee
- - - GILEAD SCIENCES, LDA
- Place of performance
- Portugal, Leiria, Leiria
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - GILEAD SCIENCES, LDA
Values and timeline
- Contract price
- €123,494.51
- Procedure base price
- €123,494.51
- Total effective price
- €123,494.51
- Publication date
- 15 March 2017
- Award date
- 9 February 2017
- Signing date
- 9 February 2017
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- CP 2015/41 - ACORDO QUADRO PARA FORNECIMENTO DE MEDICAMENTOS ANTI-INFECIOSOS: ANTIVÍRICOS E ANTIFÚNGICOS ÀS INSTITUIÇÕES E SERVIÇOS DO SERVIÇO NACIONAL DE SAÚDE
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2650669
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.